Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-07

Clinical Trial Update: Efficacy and Safety of DLBS3233 in Prediabetic Patients [Phase 3]

View source ↗

Summary

Phase 3 trial of DLBS3233 in prediabetic patients has completed. The update does not include efficacy or safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DLBS3233

Snippet

Sponsor: Dexa Medica Group | Conditions: Prediabetic | Phase 3 | Status: COMPLETED